Dolby Laboratories, Inc.
DLB · NYSE
9/26/2025 | 6/27/2025 | 3/28/2025 | 12/27/2024 | |
|---|---|---|---|---|
| Market Cap | – | – | $8 | $8 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | – | $7 | $7 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -2.7% | -14.6% | 3.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 87.1% | 86.1% | 90.3% | 88.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 19.7% | 22.7% | 39.1% | 31.2% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 16.1% | 14.6% | 24.8% | 19% |
| EPS Diluted | 0.51 | 0.48 | 0.94 | 0.7 |
| % Growth | 6.3% | -48.9% | 34.3% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |